Project Number 5R01AG063689-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator SPERLING, REISA A. Principal Investigator First Name REISA A. Principal Investigator Last Name SPERLING Awardee Organization BRIGHAM AND WOMEN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $6,944,873 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
